Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: specify (138), lay down (163), instruct (95), order (441), require (1000), demand (122)

ETD Funding Call - application form 2024

Description: NIHR Southampton BRC Education, Training and Career Development Fund Application Form Applicant details Full name Email Mobile no Contact address Current
Url: /Media/Southampton-Clinical-Research/Downloads/ETD-Funding-Call-application-form-2024.pdf

ETD Funding Call - application form

Description: NIHR Southampton BRC Education, Training and Career Development Fund Application Form Applicant details Full name Email Mobile no Contact address Current
Url: /Media/Southampton-Clinical-Research/Downloads/ETD-Funding-Call-application-form.pdf

DVd-T SC Bortezomib-Daratumumab-Dexamethasone-Thalidomide v1

Description: Details of the Chemotherapy Protocol for Myeloma.
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-T-SC-Bortezomib-Daratumumab-Dexamethasone-Thalidomide.pdf

Is there a role for next of kin?

Description: Whether admission to our hospital is recorded on paper or electronically, we faithfully record the patient's 'next of kin'. Is this
Url: /HealthProfessionals/Clinical-law-updates/Is-there-a-role-for-next-of-kin.aspx

Joint Partnership Policy and Guidance on Pre-clinical and Clinical Research Publications

Description: Joint Partnership Policy and Guidance on Pre-clinical and Clinical Research Publications ? ? ? ? Background Scope: who this policy and guidance applies to
Url: /Media/Southampton-Clinical-Research/Downloads/Joint-Partnership-Policy-and-Guidance-on-Pre-clinical-and-Clinical-Research-Publications.pdf

Meningitis trial_frequently asked questions

Description: F.A.Q.: Human nasopharyngeal colonization using a genetically modified strain of the bacteria, Neisseria lactamica This document contains information and
Url: /Media/Southampton-Clinical-Research/Researchtrials/Meningitis-trial-frequently-asked-questions.pdf

Papers Trust Board - 5 November 2024

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 05/11/2024 9:00 - 11:30 The Ark Conference Centre
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2024-Trust-documents/Papers-Trust-Board-5-November-2024.pdf

Papers Trust Board - 13 January 2026

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 13/01/2026 9:00 - 13:00 Conference Room, Heartbeat Education
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2026-Trust-documents/Papers-Trust-Board-13-January-2026.pdf

Papers Trust Board - 15 July 2025

Description: Agenda Trust Board – Open Session Date 15/07/2025 Time 9:00 - 13:00 Location Conference Room, Heartbeat Education Centre Chair
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-15-July-2025.pdf

DRD Daratumumab-Lenalidomide-Dexamethasone

Description: Chemotherapy Protocol Myeloma DRD Daratumumab-Lenalidomide-Dexamethasone Regimen • Myeloma – DRD Daratumumab-Lenalidomide-Dexamethasone Indication • Daratumumab in combination with lenalidomide and dexamethasone
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DRD-Daratumumab-Lenalidomide-Dexamethasone.pdf

1 to 10 of 19

Previous 1 2 Next